StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
William Blair Downgrades BioMarin Pharmaceutical Inc. (BMRN) to Market Perform
October 30, 2024 6:10 AM
(Updated - October 30, 2024 7:01 AM EDT)
William Blair analyst Tim F. Lugo downgraded BioMarin Pharmaceutical Inc. (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Downgrades
Next Articles
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $84 at Canaccord Genuity
October 30, 2024 6:51 AM
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $105 at Leerink Partners
October 30, 2024 6:26 AM
BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $81 at Citi
October 30, 2024 5:48 AM
BioMarin Pharma (BMRN) Tops Q3 EPS by 38c; raises guidance
October 29, 2024 4:05 PM
Form 8-K BIOMARIN PHARMACEUTICAL For: Oct 29
October 29, 2024 4:04 PM
BioMarin Announces 28% Y/Y Total Revenue Growth in the Third Quarter and Increase in Full-year 2024 Guidance; Reaffirms Long-term Guidance and Outlook
October 29, 2024 4:03 PM
